Garcia Weight Loss, Aesthetics & Hormone Therapy review

Garcia publishes a $300 monthly sermorelin offer with a three-month minimum and separate NAD⁺ prices by infusion, injection or at-home vial. The four-location Florida model and named pharmacies make the care path tangible. The clinic requires identification showing a Florida address; a fully remote pathway has not been established. Product pages do not settle the first debit, lab fees or treatment cancellation terms, so the free consultation is where to get those in writing.

Garcia Weight Loss, Aesthetics & Hormone Therapy is a Tampa Bay clinic brand operated by Everslim Centers LLC. The clinic says it has served the area since 2000 and lists South Tampa, North Tampa, Brandon/Riverview and Palm Harbor locations. Its menu includes lyophilized injectable sermorelin, NAD⁺ IV and IM care, plus an at-home IM vial. GLP-1 Premier and Standard programs describe office visits, shipped medication and a metabolic/hormone panel, but publish no complete program or start-fee amount. The transparency page names Anazao Health, Olympia Pharmaceuticals and Red Rock, plus patient-selected pharmacies for manufactured drugs.

Clinic care is centered on four Tampa Bay locations. The site requires government or state identification with a Florida address when scheduling; it does not establish a fully remote path. Its GLP-1 programs include a lab panel and either weekly or monthly visits, but that inclusion cannot be carried over to sermorelin or NAD⁺. The at-home NAD⁺ IM vial is an exception to a blanket in-person-administration description. Named pharmacy partners do not establish which one would fill a selected prescription. Terms cover the website and SMS, not a treatment refund or renewal contract; texting STOP is not treatment cancellation.

Sermorelin is advertised at $300 monthly with a three-month minimum; $900 is the arithmetic commitment, not a confirmed first charge. NAD⁺ costs $250 per 250 mg IV infusion, $500 per 500 mg infusion, $50 per clinic IM injection or $300 per at-home IM vial. Packages list three 250 mg infusions for $700, twelve IM injections for $500 or a six-month sermorelin/NAD⁺ combination for $3,120. These are session, vial and package prices, not a standing monthly NAD⁺ plan. Ask about quantities, lab and visit charges, payment timing and cancellation before starting.

Compounded where compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Garcia names pharmacy partners, and compounded sterile products are still not reviewed by FDA for purity and potency the way approved drugs are. On the evidence, naming sermorelin and NAD⁺ is the useful part, because it lets them be assessed — and they are not equivalent. Sermorelin is a GHRH analog acting on the growth-hormone axis, a real and well-described mechanism, but long-term human outcome data stays thin and no controlled trial demonstrates the body-composition, recovery or anti-aging results the category is sold on. NAD⁺ delivered by injection or infusion has no controlled human outcome trials at all; the single human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears from plasma quickly, and the forms with human trial data are the oral precursors NR and NMN, which raise blood NAD⁺ without demonstrating a clinical outcome. That is why the clinic's NAD⁺ page listing "slow down the aging process" among expected results is a claim to discount entirely. Since the clinic also runs an IV therapy line, the distinction is worth carrying in: an infusion is a route, not evidence. On the GLP-1 side, the clinic describes its program without naming the specific drug or stating whether it is branded or compounded, which is a disclosure gap on its own. Individual results vary.